Effect of Linear Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction—12-Month Follow-Up of a Randomized, Double-Blinded, Sham-Controlled Study

Sexual Medicine - Tập 6 Số 1 - Trang 1-7 - 2018
Grzegorz Fojecki1,2, Stefan Tiessen3,4, Palle Jörn Sloth Osther5,6,7,8
1Department of Urology   , Sønderborg , Denmark
2Hospital of Southern Jutland   , Sønderborg , Denmark
3Department of Urology   , Odense , Denmark
4Odense University Hospital, Odense, Denmark
5Department of Urology       , , Denmark
6Lillebælt Hospital, Denmark
7 University of Southern Denmark
8Urological Research Center       , , Denmark

Tóm tắt

Abstract Introduction Short-term data on the effect of low-intensity extracorporeal shockwave therapy (Li-ESWT) on erectile dysfunction (ED) have been inconsistent. The suggested mechanisms of action of Li-ESWT on ED include stimulation of cell proliferation, tissue regeneration, and angiogenesis, which can be processes with a long generation time. Therefore, long-term data on the effect of Li-ESWT on ED are strongly warranted. Aim To assess the outcome at 6 and 12 months of linear Li-ESWT on ED from a previously published randomized, double-blinded, sham-controlled trial. Methods Subjects with ED (N = 126) who scored lower than 25 points in the erectile function domain of the International Index of Erectile Function (IIEF-EF) were eligible for the study. They were allocated to 1 of 2 groups: 5 weekly sessions of sham treatment (group A) or linear Li-ESWT (group B). After a 4-week break, the 2 groups received active treatment once a week for 5 weeks. At baseline and 6 and 12 months, subjects were evaluated by the IIEF-EF, the Erectile Hardness Scale (EHS), and the Sexual Quality of Life in Men. Main Outcome Measures The primary outcome measure was an increase of at least 5 points in the IIEF-EF (ΔIIEF-EF score). The secondary outcome measure was an increase in the EHS score to at least 3 in men with a score no higher than 2 at baseline. Data were analyzed by linear and logistic regressions. Results Linear regression of the ΔIIEF-EF score from baseline to 12 months included 95 patients (dropout rate = 25%). Adjusted for the IIEF-EF score at baseline, the difference between groups B and A was −1.30 (95% CI = −4.37 to 1.77, P = .4). The success rate based on the main outcome parameter (ΔIIEF-EF score ≥ 5) was 54% in group A vs 47% in group B (odds ratio = 0.67, P = .28). Improvement based on changes in the EHS score in groups A and B was 34% and 24%, respectively (odds ratio = 0.47, P = .82). Conclusion Exposure to 2 cycles of linear Li-ESWT for ED is not superior to 1 cycle at 6- and 12-month follow-ups.

Từ khóa


Tài liệu tham khảo

Hatzichristou, 2017, Low-intensity extracorporeal shock waves therapy (LI-ESWT) for the treatment of erectile dysfunction: where do we stand?, Eur Urol, 71, 234, 10.1016/j.eururo.2016.06.037

Lim, 2002, The clinical safety of Viagra, Ann N Y Acad Sci, 962, 378, 10.1111/j.1749-6632.2002.tb04082.x

Giuliano, 2010, Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database, Int J Clin Pract, 64, 240, 10.1111/j.1742-1241.2009.02254.x

Clavijo, 2017, Effects of low-intensity extracorporeal shockwave therapy on erectile dysfunction: a systematic review and meta-analysis, J Sex Med, 14, 27

Lu, 2016, Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis, Eur Urol, 71, 223, 10.1016/j.eururo.2016.05.050

Qiu, 2013, Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model, J Sex Med, 10, 738

Li, 2016, Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model, Transl Androl Urol, 5, 977, 10.21037/tau.2016.11.07

Vardi, 2010, Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction, Eur Urol, 58, 243, 10.1016/j.eururo.2010.04.004

Vardi, 2012, Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study, J Urol, 187, 1769

Gruenwald, 2012, Low-intensity extracorporeal shock wave therapy—a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy, J Sex Med, 9, 259

Yee, 2014, Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study, Int J Urol, 21, 1041, 10.1111/iju.12506

Olsen, 2015, Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study, Scand J Urol, 49, 329, 10.3109/21681805.2014.984326

Kitrey, 2016, Penile low intensity shock wave treatment is able to shift pde5i nonresponders to responders: a double-blind, sham controlled study, J Urol, 195, 1550

Motil, 2016, Treatment of vasculogenic erectile dysfunction with Piezowave2 device. Application of low intensity shockwaves using novel linear shockwave tissue coverage (LSTC-ED®) technique. A prospective, multicentric, placebo-controlled study, Adv Sex Med, 6, 15, 10.4236/asm.2016.62002

Fojecki, 2017, Effect of low-energy linear shockwave therapy on erectile dysfunction—a double-blinded, sham-controlled, randomized clinical trial, J Sex Med, 14, 106

Srini, 2015, Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population, Can J Urol, 22, 7614

Fojecki, 2017, Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain, World J Urol, 35, 1, 10.1007/s00345-016-1834-2

Schulz, 2010, CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials, PLoS Med, 7, e1000251, 10.1371/journal.pmed.1000251

Angulo, 2017, Efficacy of low-intensity shock wave therapy for erectile dysfunction: a systematic review and meta-analysis, Actas Urol Esp, 41, 479, 10.1016/j.acuro.2016.07.005

Rosen, 2011, Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale, Eur Urol, 60, 1010, 10.1016/j.eururo.2011.07.053

Bechara, 2016, Twelve-month efficacy and safety of low-intensity shockwave therapy for erectile dysfunction in patients who do not respond to phosphodiesterase type 5 inhibitors, Sex Med, 4, e225, 10.1016/j.esxm.2016.06.001

Reisman, 2015, Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study, Int J Impot Res, 27, 108, 10.1038/ijir.2014.41

Pelayo-Nieto, 2015, Linear shock wave therapy in the treatment of erectile dysfunction, Actas Urol Esp, 39, 456, 10.1016/j.acuro.2014.09.010

Fode, 2017, Low-intensity extracorporeal shockwave therapy in sexual medicine: a questionnaire-based assessment of knowledge, clinical practice patterns, and attitudes in sexual medicine practitioners, Sex Med, 5, e94, 10.1016/j.esxm.2016.12.002

Dong, 2011, Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies, J Am Coll Cardiol, 58, 1378, 10.1016/j.jacc.2011.06.024

Giugliano, 2004, Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men, J Endocrinol Invest, 27, 665, 10.1007/BF03347500

Esposito, 2010, Dietary factors, Mediterranean diet and erectile dysfunction, J Sex Med, 7, 2338

Dettori, 2011, Loss to follow-up, Evid Based Spine Care J, 2, 7, 10.1055/s-0030-1267080

Lane, 2008, Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches, Pharm Stat, 7, 93, 10.1002/pst.267

Hatzichristodoulou, 2013, Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study, J Sex Med, 10, 2815